Related Experiment Video
Updated: Dec 7, 2025

04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.0K
Interim recruitment prediction for multi-center clinical trials
Szymon Urbas1, Chris Sherlock2, Paul Metcalfe3
1STOR-i Centre for Doctoral Training, Lancaster University, Lancaster, UK.
Biostatistics (Oxford, England)
|September 26, 2020
Summary
This study presents a new framework for predicting clinical trial recruitment, addressing limitations of current models. The developed methodology improves prediction accuracy for multi-center trials, especially in oncology.
Area of Science:
- Clinical trial operations
- Statistical modeling
- Biostatistics
Background:
- Existing time-homogeneous models for multi-center clinical trial recruitment often yield overly optimistic and narrow prediction intervals.
- There is a need for more accurate and robust methods to monitor, model, and predict patient recruitment in complex trial settings.
Purpose of the Study:
- To introduce a general framework for monitoring, modeling, and predicting patient recruitment in multi-center clinical trials.
- To address the limitations of existing models by accounting for decaying recruitment rates and model uncertainty.
Main Methods:
- Development of two tests for detecting decay in recruitment rates.
- Introduction of an inhomogeneous Poisson process model with a monotonically decaying intensity, adaptable to various parametric curve-shapes.
- Utilizing Bayesian model averaging for predictions, incorporating parameter and model uncertainty.
Main Results:
- The proposed framework demonstrates improved prediction accuracy compared to existing methods in simulated and real oncology trial data.
- The methodology effectively identifies unexpected changes and patterns in patient accrual.
- The tests for recruitment rate decay show reliable performance in power studies.
Conclusions:
- The new framework provides a more realistic and robust approach to predicting clinical trial recruitment, particularly for multi-center studies.
- The methodology enhances the ability to monitor trial progress and detect deviations from expected recruitment patterns.
- This work offers valuable tools for optimizing clinical trial planning and management.
Related Concept Videos
Clinical Trials: Overview
4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Clinical Trials
10.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.0K
Preclinical Development: Overview
5.6K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.6K
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
126
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
126

